Sponsored by Digital Look Events

A&D Pharma(ADPH)

Market Cap

€ 158.33m

Change Today

€ 0.00

Share Price

€ 4.75

1 Day Chart (15-May-2008)

1 Day Chart

6 Month Chart

6 Month Chart

Income & Efficiency

Latest F'cast
Div Yield 0.4% 3.0%
Div Cover -2.2 4.4
Op Mrgn 2.1% 4.5%
ROCE 10.9%  

Valuation

Latest F'cast
P/E n/a 7.6
PEG n/a n/a
Pr/Revenue 0.4 0.3
Pr/Book 0.6  

Growth

Latest F'cast
Revenue 100.7% 29.1%
PBT n/a n/a
EPS n/a n/a
DPS n/a 710.6%

A&D Pharma Fundamentals

Year Ending Revenue (€ m) Pre-tax (€ m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-05 247.25 19.84 n/a n/a n/a n/a n/a 0.0%
31-Dec-06 212.04 11.85 4.00¢ 315.8 n/a n/a n/a 0.0%
31-Dec-07 425.52 (5.65) (4.00)¢ n/a n/a n/a 1.78¢ 0.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

A&D Pharma Forecasts

Year Ending Revenue (€ m) Pre-tax (€ m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-08 549.37 24.97 62.91¢ 7.6 n/a n/a 14.43¢ 3.0%
31-Dec-09 665.75 30.49 77.05¢ 6.2 0.3 +22% 15.62¢ 2.4%

Covering analysts: Erste Bank, KBC Securities, Unicredit Markets & Invt Bank

A&D Pharma Company Announcements

Second Price Monitoring Extn 26-Mar-2008 15:45 RNS
Price Monitoring Extension 26-Mar-2008 15:40 RNS
Price Monitoring Extension 24-Jan-2008 15:40 RNS

Latest A&D Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

A&D Pharma Market Data

Currency Euro
Share Price € 4.75  
Change Today € 0.00
52 Week High € 18.50
52 Week Low € 4.75
Volume 0
Shares Issued 33.33m
Market Cap € 158.33m
Beta 0.45
RiskGrade 777

A&D Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

A&D Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div n/a n/a
Paid n/a 03-Jul-07
Amount 0.000¢ 1.78¢

Trades for --2008

Time Volume / Share Price
0 @ € 0.00